The autoreactive nature of MS exposes endothelial cells to pro-inflammatory cytokines such as interferon-gamma (IFN-g) and tumour necrosis factor (TNF) which disrupt the BBB by redistributing junctional protein expression [7]. The gene discussed is IFNG; the disease is myeloid sarcoma.